Enter assignee name

% Expired Patents = 70.0

Forward Citations = 54

Loading Chart...

4 inventors (with patents filed for the assignee):

Xiaoming Zhang (10 out of 68 patents)

Edward F Schnipper (10 out of 16 patents)

Andrew J Perlman (10 out of 14 patents)

4. James W Larrick (10 out of 56 patents)

10 patents: Sort by Forward Citations

1. 10702499 - Use of NK-1 receptor antagonists in pruritus (2020-07-07),

2. 10617671 - Use of NK-1 receptor antagonist serlopitant in pruritus (2020-04-14),

3. 10278953 - Use of NK-1 receptor antagonist serlopitant in pruritus (2019-05-07),

4. 10278952 - Use of NK-1 receptor antagonists in pruritus (2019-05-07),

5. 9974769 - Use of NK-1 receptor antagonist serlopitant in pruritus (2018-05-22),

6. 9968588 - Use of NK-1 receptor antagonists in pruritus (2018-05-15),

7. 9737508 - Use of NK-1 receptor antagonists in pruritus (2017-08-22),

8. 9737507 - Use of NK-1 receptor antagonist serlopitant in pruritus (2017-08-22),

9. 9486439 - Use of NK-1 receptor antagonist serlopitant in pruritus (2016-11-08),

10. 9474741 - Use of NK-1 receptor antagonists in pruritus (2016-10-25),

Menlo Therapeutics Inc. is a biopharmaceutical company based in Redwood City, California, focused on developing innovative therapies for dermatological conditions. The company specializes in the research and commercialization of novel treatments that address unmet medical needs in skin health. Leveraging advanced drug delivery technologies, Menlo aims to enhance patient outcomes through effective and safe therapeutic options, positioning itself as a key player in the dermatology sector.

Profile summary based on public USPTO records.